Nuclear Pore Glycoprotein 62 Genetic Variant rs9523 is Associated with Clinical Outcomes of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Adenocarcinoma Patients.
Pharmgenomics Pers Med
; 14: 1291-1302, 2021.
Article
en En
| MEDLINE
| ID: mdl-34629889
Texto completo:
1
Bases de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Pharmgenomics Pers Med
Año:
2021
Tipo del documento:
Article